Maximilian Bauer (@maxbadvancer) header
Maximilian Bauer (@maxbadvancer) profile picture

Ingenieur, Abenteurer und Kämpfer gegen chronische Krankheiten 💪 #MECFS

Cologne
Joined May 2023
Maximilian Bauer retweeted
The synergistic pharmacodynamics of Vitamin D3 and Vitamin K2: An exhaustive narrative review of evidence-based medicine on skeletal integrity, cardiovascular protection, and systemic calcium homeostasis journals.sagepub.com/doi/10.…
1
1
7
359
Maximilian Bauer retweeted
Researchers have engineered a revolutionary molecular tool that jams the internal mechanisms of prostate cancer cells to permanently halt tumor growth. A scientific team at the University of Michigan has developed an entirely new class of therapeutics called domain alteration chimeras. This innovative approach forces disease driving proteins into mismatched partnerships that turn a tumor against its own biology. By rewiring these proteins, the treatment completely disables the ability of prostate cancer cells to multiply. Prostate cancer relies heavily on specific protein complexes to survive and expand rapidly inside the body. Instead of simply blocking a single pathway, this newly developed molecule forcefully glues the androgen receptor to a secondary cellular protein. This unnatural locking mechanism destroys the internal structure of the cancer cell and causes the oncogenic system to collapse. Laboratory results demonstrate that this customized molecule is roughly one thousand times more potent than standard clinical inhibitors. It successfully triggered deep tumor regressions in preclinical models and worked effectively against highly resistant cancer cell lines. This breakthrough paves the way for designing similar molecular tools to target other aggressive diseases while keeping surrounding healthy tissue completely safe. Original Source: Luo, J., Yang, J., Tien, J.C.Y. et al. Domain-alteration chimeras rewire oncogenic complexes in prostate cancer. Nature, November 11, 2026. DOI: 10.1038/s41586-026-11262-4.
4
19
64
2,934
Maximilian Bauer retweeted
📢 Deadline Extended The submission deadline for the Special Issue “From Bench to Bedside: AAV, Lentivirus, Adenovirus, and Retrovirus in Gene Therapy” has been extended to 31 July 2027! Guest Editors: Dr. Shriarjun Shastry and Dr. Driss Elhanafi brnw.ch/21x7aIi
2
4
88
Danke an alle, die biomedizinische Forschung zu #MECFS und #LongCOVID möglich machen. Ihr stellt die Fragen, entwickelt Thesen, setzt Studien auf und um. Bitte macht weiter, wir zählen auf euch! Jetzt #ForschungSchenken und Wünsche erfüllen: t.ly/oYWzL
2
10
1
41
1,935
Maximilian Bauer retweeted
Heute werde ich 23 und verbringe meinen Geburtstag wegen ME/CFS im Bett. Viele von euch hier wissen leider selbst nur zu gut, was diese Erkrankung bedeutet. Deshalb habe ich eine Spendenaktion für die Mecfs Research Foundation gestartet. Und bereits jetzt sind über 1000€ innerhalb von einem Tag zusammengekommen! Wenn ihr die Möglichkeit habt, würde ich mich riesig über das Teilen freuen, damit mehr Menschen auf ME/CFS und die dringend notwendige Forschung aufmerksam werden. betterplace.org/de/fundraisi…
22
56
4
180
30,517
Maximilian Bauer retweeted
JUST IN: @FDA approved giredestrant (Wilserdly, @genentech, an oral ER antagonist with everolimus in ER +, HER-2 - for the treatment of adults with estrogen receptor (ER)-positive, ESR1-mutated metastatic breast cancer. Trial led by @DFCI_BreastOnc @elmayermd ! Congratulations to all the patients as well as all the investigators. Breast Medical Oncology needs their own medical boards!! @DFCI_BreastOnc @stolaney1 @DrHBurstein @PTarantinoMD
10
21
2,142
Thank you to everyone who makes biomedical research on #MECFS an #LongCOVID possible. You ask the questions, design and carry out studies, and do not give up. Please keep going, we are counting on you! Give the gift of research and make wishes come true: t.ly/G4-hA
23
1
51
1,737
FDA Approves Giredestrant + Everolimus for ESR1-Mutated, ER+/HER2− Advanced Breast Cancer: evERA Shows a 62% Reduction in the Risk of Progression or Death (HR 0.38), While OS Benefit Is Not Yet Established. #BreastCancer @OncoAlert #Bcsm fda.gov/drugs/cancer-approva…
1
5
16
774
Maximilian Bauer retweeted
8/ My practice: DOAC for nearly everyone. Fix modifiable bleeding risk first. LAAC: a true, nonreversible OAC contraindication, case by case, with real SDM. Don't read it as: "LAAC is noninferior to a DOAC." Read it as: different risks, unproven stroke protection.
1
1
1
187
Starting today, masks are required in all NIH Clinical Center patient care areas. 😷👍
19
292
14
1,396
16,616
Membership shouldn’t just be something you have. It should be something you use. Throughout the year, ISN membership connects you to education, scientific content, professional opportunities, events, and colleagues around the world. Your next opportunity might be a course. A paper. A grant. A fellowship. A connection. A congress. Or something you haven’t discovered yet. 🌍 One membership. A year of possibilities. 🔗 Explore ISN’s lower membership fees and join our global kidney health community in 2027: bit.ly/3TzOWP3
4
7
764
Maximilian Bauer retweeted
My trainer has me taking it up a notch. Push a little more. Eat a little more. Crawling my way to 92kg. It’s a slow climb from 89kg 18 months ago. It’s never overnight. Get fit if you can!
1
1
21
1,405
Maximilian Bauer retweeted
Amazing #grosspath pic by my friend Dr. Nejib Ben Yahia (Twitter: @NejibY). He takes some of the best gross photos in the world! What is the diagnosis? Answer: kikoxp.com/posts/20984 #pathologists #pathology #pedipath #pathTwitter #MedTwitter #MedStudentTwitter #usmle
1
3
13
1,679
Maximilian Bauer retweeted
What does "Amyloid Mafia" mean? Charles Piller explains the phrase. Full episode: youtu.be/K9qEx98D2Ww #Alzheimers #ResearchIntegrity #HealthLongevitySecrets
2
1
1,049
Maximilian Bauer retweeted
Meet our group member Siting Li! Siting is PhD Student @i3S_UPorto, and Master from Zhengzhou University, China. She is currently working on translational colorectal cancer nanomedicines. Find more about her work at i3s.up.pt/personal-info.php?…
2
12
409
Maximilian Bauer retweeted
⭐ New Editor's Choice Article! 📖 Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery🎯 💡 Curious about the results? 👇 🔗 mdpi.com/1999-4923/17/10/135… #Pharmaceutics #PCL #PLA #PLGA #Anticancer #DrugDelivery #EditorsChoice #OpenAccess
1
4
3
248
Maximilian Bauer retweeted
Falls das überhaupt noch jemanden interessiert: Es wurde ein neues #WissZeitVG beschlossen. Jetzt wird bestimmt alles besser! #IchBinHanna und so... bmftr.bund.de/SharedDocs/Kur…
1
3
17
760
Maximilian Bauer retweeted
📢 Deadline Extended – Special Issue in Pharmaceutics The submission deadline for the Special Issue "Biomaterials: Pharmaceutical Applications” has been extended to 30 June 2027! 💊 🔬 Guest Editor: Dr. Claudia Garnero 🔗brnw.ch/21x76ky
1
3
106